International Conference on Research in Life-sciences and Healthcare promotes innovation, interdisciplinary collaboration, and scientific advancements in health.
Research presentations, keynote lectures, healthcare innovations, biotechnology advances, networking opportunities, workshops, and multidisciplinary scientific discussions. This promotes innovation, collaboration, & scientific advancements in health.
1.
The most precise research tools for the deadliest blood cancer have been developed.
2.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
3.
What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains
4.
Brain cancer: a Q&A session.
5.
An ancient signaling pathway and 20 years of research offer hope for rare cancer
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
3.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
4.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
5.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Lung Cancer Congress®
3.
Genito-Urinary Oncology Summit 2026
4.
Future NRG Oncology Meeting
5.
ISMB 2026 (Intelligent Systems for Molecular Biology)
1.
Navigating the Complexities of Ph Negative ALL - Part XVI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
Recommended News For You
1.
Two-part prodrug system activates immune attack only in tumor's unique environment
2.
Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.
3.
Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
There has been a new target found that might stop blood cancer.
Conferences That Might Interest You
Recommended Articles For You
1.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
2.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
3.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
4.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
5.
Exploring the Unknown: Unveiling the Mysteries of GIST Tumors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation